COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,738 Articles (22,502 medRxiv, 8,236 bioRxiv)

Most recent first Previous |  Page 1193: Articles 11921-11930  | Next

COVID-19 convalescent plasma and randomized clinical trials: rebuilding confidence by explaining failures and finding signals of efficacy.
Focosi, D., Franchini, M., Pirofski, L.-a., Burnouf, T., Paneth, N., Joyner, M. J., Casadevall, A.
10.1101/2021.09.07.21263194 — Posted: 2021-09-15
Bacterial and Fungal Co-Infections among ICU COVID-19 Hospitalized Patients in a Palestinian Hospital: Incidence and Antimicrobial Stewardship
Naseef shtaya, H. A. H., Mohammad, U., Al-Shami, N., Sahoury, Y., Abukhalil, A. D., Farraj, M.
10.1101/2021.09.12.21263463 — Posted: 2021-09-15
Predictors of real-world parents acceptance to vaccinate their children against the COVID-19
Galanis, P. A., Vraka, I., Siskou, O., Konstantakopoulou, O., Katsiroumpa, A., Moisoglou, I.
10.1101/2021.09.12.21263456 — Posted: 2021-09-15
Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display
Tanaka, S., Olson, C. A., Barnes, C. O., Higashide, W., Gonzales, M., Taft, J., Richardson, A., Martin-Fernandez, M., Bogunovic, D., Gnanapragasam, P. N. P., Bjorkman, P., Spilman, P. R., Niazi, K., Rabizadeh, S., Soon-Shiong, P.
10.1101/2021.09.14.460356 — Posted: 2021-09-15
VALIDATION OF A SALIVA-BASED TEST FOR THE MOLECULAR DIAGNOSIS OF SARS-CoV-2 INFECTION
Bulfoni, M., Sozio, E., Marcon, B., De Martino, M., Cesselli, D., De Carlo, C., Martinella, R., Migotti, A., Vania, E., Zanus-Fortes, A., De Piero, J., Nencioni, E., Tascini, C., Isola, M., Curcio, F.
10.1101/2021.09.10.21263072 — Posted: 2021-09-15 Discussion: Offsite
Children and adults with mild COVID-19 symptoms develop memory T cell immunity to SARS-CoV-2
Kaaijk, P., Olivo Pimentel, V., Emmelot, M. E., Poelen, M., Cevirgel, A., Schepp, R. M., den Hartog, G., Reukers, D. F. M., Beckers, L., van Beek, J., van Els, C. A. C. M., Meijer, A., Rots, N. Y., de Wit, J.
10.1101/2021.09.10.21263333 — Posted: 2021-09-15
Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severity
Violan, C., Toran, P., Quirant, B., Lamonja-Vicente, N., Carrasco-Ribelles, L. A., Chacon, C., Manresa-Dominguez, J. M., Ramos-Roure, F., Roso-Llorach, A., Pujol, A., Ouchi, D., Monteagudo, M., Montero, P., Garcia-Sierra, R., Armestar, F., Dacosta-Aguayo, R., Dolade, M., Prat, N., Bonet, J. M., Clotet, B., Blanco, I., Prado, J. G., Martinez-Caceres, E. M., ProHEpiC-19 Investigators
10.1101/2021.09.10.21262527 — Posted: 2021-09-15
Localising Vaccination Services: Qualitative Insights on an Orthodox Jewish Collaboration with Public health during the UK coronavirus Vaccine Programme
Kasstan, B., Mounier-Jack, S., Letley, L., Gaskell, K. M., Roberts, C. h., Stone, N., Lal, S., Eggo, R. M., Marks, M., Chantler, T.
10.1101/2021.09.10.21263372 — Posted: 2021-09-15
Social-economic drivers overwhelm climate in underlying the COVID-19 early growth rate
Liu, Z.
10.1101/2021.09.10.21263383 — Posted: 2021-09-15
High viral SARS-CoV-2 load in placenta of patients with hypertensive disorders after COVID-19 during pregnancy
FABRE, M., CALVO, P., RUIZ-MARTINEZ, S., PERAN, M., OROS, D., MEDEL, A., STRUNK, M., BENITO, R., SCHOORLEMMER, J., PAULES, C.
10.1101/2021.09.07.21261607 — Posted: 2021-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).